CA2126441A1 - Microcrystalline Cellulose Spheronization Composition - Google Patents

Microcrystalline Cellulose Spheronization Composition

Info

Publication number
CA2126441A1
CA2126441A1 CA 2126441 CA2126441A CA2126441A1 CA 2126441 A1 CA2126441 A1 CA 2126441A1 CA 2126441 CA2126441 CA 2126441 CA 2126441 A CA2126441 A CA 2126441A CA 2126441 A1 CA2126441 A1 CA 2126441A1
Authority
CA
Canada
Prior art keywords
composition
microcrystalline cellulose
hydrocolloid
spheronization
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2126441
Other languages
French (fr)
Other versions
CA2126441C (en
Inventor
David F. Erkoboni
Scott A. Fiore
Thomas A. Wheatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2126441A1 publication Critical patent/CA2126441A1/en
Application granted granted Critical
Publication of CA2126441C publication Critical patent/CA2126441C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/005—Processes for mixing polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/14—Water soluble or water swellable polymers, e.g. aqueous gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers

Abstract

A particulate co-processed unattrited microcrystalline cellulose: hydrocolloid composition wherein the respective components are present in a weight ratio of from about 99:1 to 70:30. The composition is useful as a spheronizing agent for producing spheroids of uniform size and sphericity and having high drug loadings. The composition is produced by drying a slurry of the microcrystalline cellulose in an aqueous solution of the hydrocolloid. The preferred hydrocolloid is methyl cellulose.
CA002126441A 1991-12-30 1992-11-18 Microcrystalline cellulose spheronization composition Expired - Fee Related CA2126441C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81602791A 1991-12-30 1991-12-30
US816,027 1991-12-30
PCT/US1992/009983 WO1993012768A1 (en) 1991-12-30 1992-11-18 Microcrystalline cellulose spheronization composition

Publications (2)

Publication Number Publication Date
CA2126441A1 true CA2126441A1 (en) 1993-07-08
CA2126441C CA2126441C (en) 1999-12-21

Family

ID=25219497

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002126441A Expired - Fee Related CA2126441C (en) 1991-12-30 1992-11-18 Microcrystalline cellulose spheronization composition

Country Status (16)

Country Link
US (1) US5725886A (en)
EP (1) EP0619731B1 (en)
JP (1) JP2628230B2 (en)
CN (1) CN1074228A (en)
AT (1) ATE196733T1 (en)
AU (1) AU663146B2 (en)
BR (1) BR9206996A (en)
CA (1) CA2126441C (en)
DE (1) DE69231499T2 (en)
ES (1) ES2150438T3 (en)
FI (1) FI943121A (en)
IL (1) IL104087A (en)
MX (1) MX9207438A (en)
NO (1) NO942457D0 (en)
WO (1) WO1993012768A1 (en)
ZA (1) ZA929161B (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
PT948318E (en) * 1996-08-14 2004-06-30 Yamanouchi Europ Bv GRANULATES UNDERSTANDING A SOLUBLE COMPOUND IN WATER AND CELLULOSE
CN1086189C (en) * 1997-06-12 2002-06-12 食品机械和化工公司 Ultra-fine microcrystalline cellulose compositions and process for their manufacture
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
ATE365541T1 (en) 1999-09-29 2007-07-15 Scherer Technologies Inc R P GRANULES OF MEDICINAL SALTS WITH HYDROLIZED CELLULOSE
MXPA02009534A (en) 2000-03-30 2003-05-14 Squibb Bristol Myers Co Sustained release beadlets containing stavudine.
CZ20032138A3 (en) * 2001-02-05 2005-03-16 R. P. Scherer Technologies, Inc. Methods and compositions for reducing the taste of pharmaceutically active agents
JP2004530679A (en) * 2001-04-26 2004-10-07 ブリストル−マイヤーズ　スクイブ　カンパニー Pharmaceutical tablets with high API content
WO2003096976A2 (en) 2002-05-14 2003-11-27 Fmc Corporation Microcrystalline cewllulose compositions
WO2006082525A1 (en) * 2005-02-04 2006-08-10 Philip Morris Products S.A. Cigarette and filter with cellulosic flavor addition
US20070000505A1 (en) * 2005-02-24 2007-01-04 Philip Morris Usa Inc. Smoking article with tobacco beads
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
FR2898056B1 (en) * 2006-03-01 2012-01-20 Ethypharm Sa SQUEEZE-RESISTANT TABLETS TO PREVENT UNLAWFUL MISUSE
BRPI0714586A2 (en) * 2006-07-28 2013-05-07 Farmaprojects S A Metropolol prolonged release pharmaceutical formulation and process for its preparation
JP2010507676A (en) * 2006-10-27 2010-03-11 エフ エム シー コーポレーション Dry granulating binder, product and use thereof
ATE476176T1 (en) * 2007-03-02 2010-08-15 Farnam Co Inc SUSTAINED-RELEASE TABLETS CONTAINING WAX-LIKE MATERIAL
US9888712B2 (en) 2007-06-08 2018-02-13 Philip Morris Usa Inc. Oral pouch products including a liner and tobacco beads
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CA2702055C (en) * 2007-10-10 2017-12-12 Mallinckrodt Baker, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
EP2376067A2 (en) * 2008-11-19 2011-10-19 Avantor Performance Materials, Inc. Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US9144625B2 (en) 2008-11-27 2015-09-29 Speciality Fibres And Materials Ltd. Cellulose ethylsulfonate-based absorbent material
US9221963B2 (en) 2008-11-27 2015-12-29 Speciality Fibres And Materials Ltd. Absorbent material
US8377215B2 (en) 2008-12-18 2013-02-19 Philip Morris Usa Inc. Moist botanical pouch processing
US8863755B2 (en) * 2009-02-27 2014-10-21 Philip Morris Usa Inc. Controlled flavor release tobacco pouch products and methods of making
US20110277781A1 (en) 2010-03-26 2011-11-17 Philip Morris Usa Inc. Methods for improving quality of mainstream smoke and multicomponent filters and smoking articles therefor
US10051884B2 (en) 2010-03-26 2018-08-21 Philip Morris Usa Inc. Controlled release mentholated tobacco beads
WO2013052118A1 (en) 2011-10-05 2013-04-11 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
JP6188030B2 (en) 2011-10-05 2017-08-30 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ Stabilizer composition for microcrystalline cellulose and carboxymethylcellulose, method for producing the composition, and food product
BR112014013792B8 (en) 2011-12-09 2020-11-10 Dupont Nutrition Usa Inc co-rubbed stabilizing composition comprising high-substitution, low-viscosity carboxymethyl cellulose, food, industrial composition, and method for making the stabilizing composition
CN105085992B (en) * 2015-09-16 2017-12-29 珠海市东辰医药科技有限公司 A kind of preparation technology of modified microcrystalline cellulose
CN105193738B (en) * 2015-09-21 2018-09-04 珠海市东辰制药有限公司 A kind of preparation process of microcrystalline cellulose pellet
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1010477A (en) * 1962-05-15 1965-11-17 Fmc Corp Method of making cellulose crystallite aggregates in particulate form and product of such method
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4421778A (en) * 1982-11-04 1983-12-20 Rich Products Corporation Freezer stable whipped ice cream and milk shake food products
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Also Published As

Publication number Publication date
FI943121A0 (en) 1994-06-29
WO1993012768A1 (en) 1993-07-08
DE69231499D1 (en) 2000-11-09
US5725886A (en) 1998-03-10
ATE196733T1 (en) 2000-10-15
EP0619731B1 (en) 2000-10-04
DE69231499T2 (en) 2001-05-03
IL104087A0 (en) 1993-05-13
CN1074228A (en) 1993-07-14
ZA929161B (en) 1993-05-25
JPH06511255A (en) 1994-12-15
NO942457L (en) 1994-06-29
EP0619731A4 (en) 1995-05-03
CA2126441C (en) 1999-12-21
BR9206996A (en) 1995-12-05
MX9207438A (en) 1993-06-01
JP2628230B2 (en) 1997-07-09
ES2150438T3 (en) 2000-12-01
IL104087A (en) 1998-10-30
AU663146B2 (en) 1995-09-28
FI943121A (en) 1994-06-29
EP0619731A1 (en) 1994-10-19
NO942457D0 (en) 1994-06-29
AU3179393A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
CA2126441A1 (en) Microcrystalline Cellulose Spheronization Composition
ES8704977A1 (en) Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation.
CA2089430A1 (en) Aqueous pharmaceutical suspension for pharmaceutical active
SE8503092D0 (en) PROCEDURE FOR MANUFACTURING A GUAR-GUM PRODUCT
JPS5454169A (en) Compound
ZA877542B (en) Spray dried acetaminophen
KR880000090A (en) Method for preparing sustained release ibuprofen formulation
IE41923L (en) Suspension of xanthan gum
IE41924L (en) Suspension of alginate
EP0395095A3 (en) Metastable metal colloids and preparation
CA2023815A1 (en) Riboflavin granules containing no inactive ingredient
Lin et al. Effect of Acid Type, Acetic Acid and Sodium Carboxymethyl Cellulose Consentrations on the Formation, Micromeritic, Dissolution and Floating Properties of Theophylline Chitosan Microcapsules
GR3020828T3 (en) Sustained release suppositories and a process for preparation
JPS5455054A (en) Water-despersible compound
JPS5474855A (en) Preparation of finely divided soluble cellulose derivative
JPS57142911A (en) Absorption-improving agent
CA1243956A (en) Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby
US5185336A (en) Method for producing substantially pure vitamin powders
CA2015632A1 (en) Stable solutions of rebeccamycin analog and preparations thereof
CA2105793A1 (en) Process for producing compositions for ruminants
JPS5550863A (en) Preparation of water-soluble biotin pharmaceutical
ATE38236T1 (en) STEROID DERIVATIVES.
CA2002552A1 (en) Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine
JPS6468317A (en) Durative preparation
JPS565412A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20111118